TABLE 4 p53, bcl-2, bax, ER, and PR Expression According to Tumor Stage in Uterine Endometrioid Adenocarcinoma

From: Immunohistochemical Profile of Endometrial Adenocarcinoma: A Study of 61 Cases and Review of the Literature

Stage No. Cases p53+ No. (%) bcl-2+ No. (%) bax+ No. (%) ER+ No. (%) PR+ No. (%)
Earlya 20 3 (15) 15 (75) 11 (55) 20 (100) 20 (100)
Advancedb 20 11 (55) 11 (55) 8 (40) 8 (40) 9 (45)
   p =.006 p =.07 p =.40 p =.0001 p =.0006
  1. aa Stages IA to IIB.
  2. bb Stages IIA to IVB.